Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Impact of implementing alerts about medication black-box warnings in electronic health records.

Yu DT, Seger DL, Lasser KE, et al. Impact of implementing alerts about medication black-box warnings in electronic health records. Pharmacoepidemiol Drug Saf. 2011;20(2):192-202. doi:10.1002/pds.2088.

Save
Print
September 29, 2017
Yu DT, Seger DL, Lasser KE, et al. Pharmacoepidemiol Drug Saf. 2011;20(2):192-202.
View more articles from the same authors.

Preventing overuse of potentially dangerous medications has continued to be a challenge for the safety movement, despite increasing use of technological solutions such as computerized order entry and clinical decision support. This study targeted prescribing for drugs classified as requiring a black box warning by implementing reminders within an ambulatory electronic medical record. Certain specific alerts, such as warning against prescribing drugs contraindicated in pregnancy or those with high potential for drug–drug interactions, were effective. However, overall prescribing of contraindicated medications did not decrease. Prior studies have also found limited benefit from prescribing reminders in ambulatory care, and a recent systematic review found that point-of-care clinician reminders, such as those used in this study, generally achieved only limited successes.

Save
Print
Cite
Citation

Yu DT, Seger DL, Lasser KE, et al. Impact of implementing alerts about medication black-box warnings in electronic health records. Pharmacoepidemiol Drug Saf. 2011;20(2):192-202. doi:10.1002/pds.2088.